Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Long-Term Deferred Tax (2020 - 2025)

Historic Long-Term Deferred Tax for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $10.9 million.

  • Cellebrite DI's Long-Term Deferred Tax fell 173.41% to $10.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.9 million, marking a year-over-year decrease of 173.41%. This contributed to the annual value of $10.9 million for FY2025, which is 173.41% down from last year.
  • According to the latest figures from Q4 2025, Cellebrite DI's Long-Term Deferred Tax is $10.9 million, which was down 173.41% from -$1.8 million recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's Long-Term Deferred Tax ranged from a high of $12.6 million in Q3 2022 and a low of -$2.2 million during Q3 2024
  • In the last 5 years, Cellebrite DI's Long-Term Deferred Tax had a median value of $10.3 million in 2021 and averaged $8.1 million.
  • Data for Cellebrite DI's Long-Term Deferred Tax shows a peak YoY increase of 5763.1% (in 2024) and a maximum YoY decrease of 12293.51% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Cellebrite DI's Long-Term Deferred Tax stood at $9.8 million in 2021, then grew by 27.66% to $12.5 million in 2022, then plummeted by 43.86% to $7.0 million in 2023, then soared by 57.63% to $11.1 million in 2024, then decreased by 1.73% to $10.9 million in 2025.
  • Its last three reported values are $10.9 million in Q4 2025, -$1.8 million for Q3 2025, and $12.6 million during Q2 2025.